Tellgen Corp
SZSE:300642
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tellgen Corp's latest stock split occurred on Sep 16, 2021
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Tellgen Corp traded at 62.8099 per share. Afterward, the share price was about 34.0978.
The adjusted shares began trading on Sep 16, 2021. This was Tellgen Corp's 2nd stock split, following the previous one in May 29, 2018.
Global
Stock Splits Monitor
| Date | Company | Split | Pre-Split Price | Post-Split Price | |
|---|---|---|---|---|---|
|
Apr 28, 2026
|
|
Kura Sushi Inc
TSE:2695
|
2-for-1
x2
|
3565 1782.5 JPY | 1745 1745 JPY |
|
Apr 28, 2026
|
|
Sanki Engineering Co Ltd
TSE:1961
|
3-for-1
x3
|
7020 2340 JPY | 2413 2413 JPY |
|
Apr 28, 2026
|
|
Hyterra Ltd
ASX:HYT
|
65-for-64
x1.015625
|
0.015 0.0148 AUD | 0.015 0.015 AUD |
|
Apr 28, 2026
|
|
Fit Corp
TSE:1436
|
3-for-1
x3
|
4065 1340 JPY | 1269 1269 JPY |
|
Apr 28, 2026
|
|
Visual Processing Japan Co Ltd
TSE:334A
|
2-for-1
x2
|
1844 922 JPY | 965 965 JPY |
2695
1961
HYT
1436
334A
Tellgen Corp
Glance View
Tellgen Corp. engages in the developing, manufacturing and marketing of molecular diagnostic products. The company is headquartered in Shanghai, Shanghai and currently employs 810 full-time employees. The company went IPO on 2017-04-21. The firm's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.
